Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Far from "disappointing".

Literature DB >> 24484334

Far from "disappointing".

Raymond B Penn¹.

Abstract

Mesh：

Substances：

Year: 2014 PMID： 24484334 PMCID： PMC5442964 DOI： 10.1164/rccm.201306-1143LE

Source DB: PubMed Journal: Am J Respir Crit Care Med ISSN： 1073-449X Impact factor: 21.405

× No keyword cloud information.

7 in total

Review 1. New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.

Authors: J K L Walker; R B Penn; N A Hanania; B F Dickey; R A Bond
Journal: Br J Pharmacol Date: 2011-05 Impact factor: 8.739

2. What doesn't kill may not make you stronger. β-blockers for asthma.

Authors: Shamsah Kazani; Elliot Israel
Journal: Am J Respir Crit Care Med Date: 2013-06-15 Impact factor: 21.405

3. β2-Adrenoceptor agonists are required for development of the asthma phenotype in a murine model.

Authors: Vaidehi J Thanawala; Gloria S Forkuo; Nour Al-Sawalha; Zoulikha Azzegagh; Long P Nguyen; Jason L Eriksen; Michael J Tuvim; Thomas W Lowder; Burton F Dickey; Brian J Knoll; Julia K L Walker; Richard A Bond
Journal: Am J Respir Cell Mol Biol Date: 2012-11-29 Impact factor: 6.914

4. A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling.

Authors: James W Wisler; Scott M DeWire; Erin J Whalen; Jonathan D Violin; Matthew T Drake; Seungkirl Ahn; Sudha K Shenoy; Robert J Lefkowitz
Journal: Proc Natl Acad Sci U S A Date: 2007-10-09 Impact factor: 11.205

5. Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma.

Authors: Zsuzsanna Callaerts-Vegh; Kenda L J Evans; Noornabi Dudekula; Donald Cuba; Brian J Knoll; Patrick F K Callaerts; Heather Giles; Felix R Shardonofsky; Richard A Bond
Journal: Proc Natl Acad Sci U S A Date: 2004-04-06 Impact factor: 11.205

6. Impedance responses reveal β₂-adrenergic receptor signaling pluridimensionality and allow classification of ligands with distinct signaling profiles.

Authors: Wayne Stallaert; Jonas F Dorn; Emma van der Westhuizen; Martin Audet; Michel Bouvier
Journal: PLoS One Date: 2012-01-05 Impact factor: 3.240

7. Randomized placebo-controlled trial to evaluate chronic dosing effects of propranolol in asthma.

Authors: Philip M Short; Peter A Williamson; William J Anderson; Brian J Lipworth
Journal: Am J Respir Crit Care Med Date: 2013-06-15 Impact factor: 21.405

7 in total

4 in total

Far from "disappointing".

Review 1. New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.

2. What doesn't kill may not make you stronger. β-blockers for asthma.

3. β2-Adrenoceptor agonists are required for development of the asthma phenotype in a murine model.

4. A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling.

5. Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma.

6. Impedance responses reveal β₂-adrenergic receptor signaling pluridimensionality and allow classification of ligands with distinct signaling profiles.

7. Randomized placebo-controlled trial to evaluate chronic dosing effects of propranolol in asthma.

Review 1. Ligand bias prevents class equality among beta-blockers.

Review 2. G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Review 3. Bronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones.

4. Airway smooth muscle and airway hyperresponsiveness in asthma: mechanisms of airway smooth muscle dysfunction.